Paul Hartmann AGSTU:PHH2 61 FCF Yield % is 21.16 as of Jul. 03, 2026, which is 247% above its 10-year median of 6.09. GuruFocus rates STU:PHH2 with a GF Score™ of 61/100 and a GF Value™ of €229.60 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 858 Medical Devices & Instruments companies, Paul Hartmann AG ranks better than 98.02% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Paul Hartmann AG's FCF Yield % or its related term are showing as below:
STU:PHH2'
s FCF Yield % Range Over the Past 10 Years
Min: -18.64 Med: 6.09 Max: 21.58
Current: 21.16
During the past 13 years, the highest FCF Yield % of Paul Hartmann AG was 21.58%. The lowest was -18.64%. And the median was 6.09%.
STU:PHH2's FCF Yield % is ranked better than 98.02% of 858
companies
in the Medical Devices & Instruments industry
Industry Median: -0.445
vs STU:PHH2: 21.16
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Paul Hartmann AG FCF Yield % Related Terms
Paul Hartmann AG FCF Yield % Historical Data
* Premium members only.
The historical data trend for Paul Hartmann AG's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:PHH2 vs ISRG, BDX, MDLN: FCF Yield % Comparison
For the Medical Instruments & Supplies subindustry, Paul Hartmann AG's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paul Hartmann AG FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Paul Hartmann AG's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Paul Hartmann AG's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paul Hartmann AG (STU:PHH2) has a FCF Yield % of 21.16 as of Jul. 03, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Paul Hartmann AG and its competitors. This is 247% above median its historical median of 6.09. According to the industry distribution chart, Paul Hartmann AG ranks #17 out of 858 companies in the Medical Devices & Instruments industry, placing it in the top 2%.
Is Paul Hartmann AG's FCF Yield % too high?
Paul Hartmann AG's current FCF Yield % of 21.16 is 247% above median its 10-year median of 6.09. Based on the distribution chart, Paul Hartmann AG ranks #17 out of 858 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Paul Hartmann AG has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Paul Hartmann AG's FCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Paul Hartmann AG ranks #17 out of 858 companies for FCF Yield %. This places Paul Hartmann AG in the top 2% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Paul Hartmann AG and its competitors. Paul Hartmann AG's current FCF Yield % is 21.16, which is 247% above median its own 10-year median of 6.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paul Hartmann AG stock overvalued right now?
Based on GuruFocus' analysis, Paul Hartmann AG (STU:PHH2) is currently considered Modestly Undervalued. The stock's GF Value™ is €229.60, compared to a current price of €204.00 — trading 11.1% below its estimated fair value. The current FCF Yield % is 21.16, which is 247% above median its 10-year median of 6.09. Paul Hartmann AG's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Paul Hartmann AG (STU:PHH2), the current FCF Yield % is 21.16 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paul Hartmann AG (STU:PHH2) Overvalued in 2026?
Based on GuruFocus' analysis, Paul Hartmann AG stock appears to be undervalued.
The current stock price of €204.00 is trading 11.1% below its estimated GF Value™ of €229.60.
GuruFocus considers Paul Hartmann AG to be Modestly Undervalued.
Key valuation signals for STU:PHH2:
FCF Yield %: 21.16 (247% above median its 10-year median of 6.09)
GF Value™: €229.60 vs. price of €204.00 (11.1% below fair value)
No single metric tells the full story. See the STU:PHH2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.
61GF Score
Get the complete analysis for STU:PHH2
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:PHH2 has been successfully added to your 
